Department of Basic Pathology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan; Department of Laboratory Medicine, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Department of Urology, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan.
Hum Pathol. 2019 Feb;84:71-80. doi: 10.1016/j.humpath.2018.09.007. Epub 2018 Sep 25.
Using analysis of allelic loss (loss of heterozygosity [LOH]), we previously reported a putative progression pathway from germ cell neoplasia in situ (GCNIS) to seminoma and then to embryonal carcinoma in mixed-type testicular germ cell tumors. To identify the genetic backgrounds related to the progression of nonseminomatous germ cell tumor, patterns of LOH were studied in seminoma components in mixed tumors (18 cases), pure seminomas (20 cases), and coexisting GCNIS lesions. Each tumor was assessed for LOH at 22 polymorphic loci located on 12 chromosomal arms: 3q, 5q, 6p, 9p, 10q, 11p, 12p, 12q, 13q, 17p, 17q, and 18q. For all informative loci, the frequency of LOH in seminoma components in mixed tumors was significantly higher than that in pure seminomas (32% [96/302 loci] versus 19% [60/323 loci], P < .0001). The frequency of LOH in GCNIS lesions was not significantly different between the 2 tumor groups. The frequencies of LOH at chromosomes 6p and 10q were significantly higher in seminoma components in mixed tumors than in pure seminomas (P = .020 and P = .0041, respectively). Immunohistochemical analysis demonstrated a close association between the allelic status of the 10q23 locus and levels of phosphatase and tensin homolog deleted from chromosome 10 protein expression in seminoma (P = .00051). These data indicate that the seminoma, which has a potential to progress to nonseminomatous germ cell tumor, already exhibits several genetic changes including allelic losses of 6p and 10q, unlike pure seminoma.
先前,我们通过分析等位基因缺失(杂合性丢失,loss of heterozygosity,LOH)发现了从生殖细胞瘤原位(germ cell neoplasia in situ,GCNIS)到精原细胞瘤,再到混合性生殖细胞肿瘤中胚胎癌的可能进展途径。为了确定与非精原细胞瘤性生殖细胞肿瘤进展相关的遗传背景,我们对混合性肿瘤(18 例)、单纯精原细胞瘤(20 例)和共存 GCNIS 病变中的精原细胞瘤成分进行了 LOH 模式研究。在每个肿瘤中,我们在 12 条染色体臂上的 22 个多态性位点评估了 LOH:3q、5q、6p、9p、10q、11p、12p、12q、13q、17p、17q 和 18q。对于所有信息性位点,混合性肿瘤中精原细胞瘤成分的 LOH 频率明显高于单纯精原细胞瘤(32%[302 个位点中的 96 个]比 19%[323 个位点中的 60 个],P < .0001)。2 组肿瘤中的 GCNIS 病变的 LOH 频率无明显差异。在混合性肿瘤中,6p 和 10q 染色体上 LOH 的频率明显高于单纯精原细胞瘤(分别为 P = .020 和 P = .0041)。免疫组化分析显示,10q23 位点的等位状态与精原细胞瘤中磷酸酶和张力蛋白同源物缺失 10 号染色体蛋白表达水平密切相关(P = .00051)。这些数据表明,与单纯精原细胞瘤不同,具有进展为非精原细胞瘤性生殖细胞肿瘤潜能的精原细胞瘤已经存在包括 6p 和 10q 等位基因缺失在内的多种遗传改变。